Neoplasia/BPH

	Monthly high-dose cholecalciferol supplementation in prostate cancer patients (ProsD trial): A nested analysis of vitamin D metabolites, metabolic ratios, and biochemical safety. Cancer Epidemiol Tan C, David MC, Anderson PH, Mason RS, Fraser DR, Kimlin MG, Sawyer RK, Amirmostofian M, Frydenberg M, Yaxley JW, Gillatt D, Woo H, Rashid P, Gardiner R', Rasiah K, Patel MI, Gurney H, Smith DP, Nair-Shalliker V. PMID: 42913061 [PubMed - as supplied by publisher]
	A Head-to-Head Comparison of Detection Rate and Tumor Uptake of FAPI, PSMA, and FDG PET/CT in Newly Diagnosed High-risk Prostate Cancer. Clin Nucl Med Zhang W, Dong Y, Xu L, Liao P, Du X, Hu C, Peng Z, Lai L, Zheng Z, Pan J, Zhu Y, Liu J, Chen R, Dong L, Xue W. PMID: 42912579 [PubMed - as supplied by publisher]
	Real-world comparative outcomes of first-line immune combinations (ICI-ICI vs ICI-TKI) in metastatic renal cell carcinoma with sarcomatoid features. Oncoimmunology Rebuzzi SE, Di Costanzo F, Filippi R, Rescigno P, Fornarini G, Signori A, Masini C, Iacovelli R, Fanelli M, Dalla Volta A, Di Napoli M, Roviello G, Guida A, Lolli C, Caserta C, Berardi R, Sorarù M, Lombardo L, Pierantoni F, Verzoni E, Mennitto A, Scagliarini S, Tucci M, Vitale MG, Messina C, Bonomi L, Tondulli L, Deppieri FM, La Russa F, Formisano L, Ortega C, Maiorano BA, Dri A, Zai S, Cocorocchio E, De Tursi M, Fantinel E, Conteduca V, Nasso C, Sansi C, Nolè F, Zago G, Bronte E, Bozza G, Bertolotti F, Montobbio N, Banna GL, Buti S, Bimbatti D. PMID: 42912018 [PubMed - indexed for MEDLINE]
	An interpretable contrast-enhanced CT-based cross-attention transformer model for predicting progression-free survival in muscle-invasive bladder cancer: a multicenter study. Abdom Radiol (NY) Liu Y, Xu Z, Xia J, Guo L, Hou W, Qu B, Huang Y, Yang S, Li S, Zhang Z, Wang H. PMID: 42911393 [PubMed - as supplied by publisher]
	Novel Imaging Techniques Prior to Surgical Management of Invasive Bladder Cancer: A Systematic Review. Curr Urol Rep Hijazi M, Hanna J, Sykes J, Golombos D. PMID: 42911355 [PubMed - indexed for MEDLINE]
	Patient-reported outcome sub-analysis of a phase 2 trial of bladder preservation therapy with atezolizumab and radiation therapy (BPT-ART) for invasive bladder cancer. Int J Clin Oncol Mathis BJ, Nagumo Y, Kimura T, Ishikawa H, Sekino Y, Maruo K, Kageyama Y, Ushijima H, Kamei J, Yamashita H, Azuma H, Nihei K, Naiki T, Tomita N, Kobayashi Y, Yoshio K, Matsumoto T, Yoshitake T, Osawa T, Nishioka K, Kita Y, Mizowaki T, Tsuzuki T, Hashimoto K, Nishiyama H. PMID: 42911315 [PubMed - as supplied by publisher]
	Before the seeds arrive: pre-metastatic niche orchestration in bladder cancer. Cancer Metastasis Rev Xu DM, Li M, Lin H, Zhuang XY, Han H, He W, Ou ZY. PMID: 42911273 [PubMed - indexed for MEDLINE]
	Integrative topological and longitudinal transcriptomic analyses identify a 14-gene interferon-stimulated module associated with acquired sunitinib resistance in clear cell renal cell carcinoma. J Chemother Chu W, Wang F, Bi L, Fu X. PMID: 42911236 [PubMed - as supplied by publisher]
	Does GATA3 Expression Contribute to the Diagnosis of Renal Tumors With Eosinophilic/Oncocytic Features? Appl Immunohistochem Mol Morphol Sars, Yaman B, Özdemir H, Utku C, Kalemci S, Tekin A, Sait . PMID: 42910784 [PubMed - as supplied by publisher]
	Transformer-Based Deep Learning Integrating Multi-Regional MRI and Clinical Features for Predicting Biochemical Recurrence After Radical Prostatectomy: A Multicenter Study. Cancer Med Zhou M, Lu K, Liu Y, Xie Z, Lin B, Yang Q, Chen R, Yu L, Zhao Y. PMID: 42910549 [PubMed - indexed for MEDLINE]
	Special AT-rich sequence-binding protein 2-positive primary small cell neuroendocrine carcinoma of the urinary bladder: A diagnostic pitfall. Indian J Urol Soni A, Singh A, Kaur H. PMID: 42910386 [PubMed]
	The relationship between 5Î±-reductase inhibitors and the presence of following open angle glaucoma: a TriNetX cohort study. Int J Med Sci Lee CY, Yang SF, Su SC, Chang YL, Huang JY, Yeh CB, Huang PH, Chang CK. PMID: 42910139 [PubMed - indexed for MEDLINE]
	Perioperative apalutamide in high-risk localized or locally advanced prostate cancer: Is PROTEUS trial practice changing? Indian J Urol Huzaifa M. PMID: 42910136 [PubMed]
	Targeted biopsy plus systematic biopsy versus targeted saturation biopsy plus systematic biopsy for the detection of clinically significant prostate cancer: A comparative study. Indian J Urol Varshney A, Sharma U, Goel H, Vivekanandam V. PMID: 42910122 [PubMed]
	Endoplasmic reticulum-mitochondria contact sites in benign prostatic hyperplasia: evidence integration and mechanistic hypotheses. Front Immunol Liu L, Fu M, Wang Z. PMID: 42909985 [PubMed - indexed for MEDLINE]
	Comparison of short-term oncological and functional outcomes between the da Vinci and toumai platforms in robotic radical prostatectomy. J Robot Surg Buffa A, Tobia I, Martinez PF, Romeo A, Villamil W. PMID: 42909741 [PubMed - indexed for MEDLINE]
	Clinical response outweighs baseline nodal stage in treatment selection and survival of clinically node-positive bladder cancer. World J Urol Albers LF, van Gennep EJ, van der Heijden MS, Pos FJ, van Rhijn BWG, Vis AN, Mertens LS. PMID: 42909637 [PubMed - indexed for MEDLINE]
	Can We Omit Systematic Biopsies in Men with a Positive MRI During Repeat Biopsies for Active Surveillance for Prostate Cancer? Results from the PRIAS Study. Eur Urol Open Sci Lodder JJ, Remmers S, Graefen M, Lozano-Uruñuela F, Marenghi C, Papavassilis P, Rannikko A, Somford D, Staerman F, Sugimoto M, Tully KH, van den Bergh RCN, Roobol MJ, Prostate Cancer Research International: Active Surveillance (PRIAS) consortium. PMID: 42909178 [PubMed]
	Population-specific molecular features and clinical significance of urinary tumor DNA mutations in Chinese patients with newly diagnosed non-muscle-invasive bladder cancer. Front Oncol Sun Z, Xie R, Pan J, Zhu Y, Shen Y, Gu C, Ma C, Jin S, Wang H, Ye D, Zhu Y, Wu J. PMID: 42908741 [PubMed]
	Pembrolizumab-induced fulminant type 1 diabetes mellitus: a case report and literature review. Front Endocrinol (Lausanne) Sun S, Su L, Ma X, Dou J. PMID: 42908608 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 192254

Page 1 of 9613



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy